This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
23 Oct 2019

CPHI 2019: Rousselot Biomedical presents a new study on X-Pure®

Rousselot Biomedical, Booth 120D21, CPhI BioProduction, 5 - 7 November 2019Rousselot, the leading global manufacturer of collagen-based solutions, will attend this year’ s CPHI at the BioProduction area.

Rousselot Biomedical team will welcome visitors interested in low endotoxin gelatins and collagens for in-body medical use or for biomedical research.

Rousselot, a Darling Ingredient global brand and the leading global manufacturer of collagen-based solutions, will attend this year’ s CPHI at the BioProduction area. Rousselot Biomedical team will welcome visitors interested in low endotoxin gelatins and collagens for in-body medical use or for biomedical research. They will be available to detail the results of a recent study showing that the endotoxin-purified gelatin X-Pure® provides a superior environment for (stem) cell viability and differentiation.

Why does endotoxin matter?Endotoxins, also referred to as “LPS” or Lipopolysaccharides, are large molecules that are found in the outer membrane of gram-negative bacteria and have profound in vivo responses. They can form micelles/vesicles with high molecular weight.

The human immune system can detect and react to LPS at very low levels1, not only this triggers an inflammatory reaction in the human body, it is also undesirable in clinical applications and regulated by the FDA for medical devices. Also, during in vitro testing, endotoxin levels as low as 0.01 Endotoxin Units (EU) / ml can significantly alter the growth and functionality of cells in culture.

Investigating the influence of endotoxins in gelatin hydrogels on cellular activityA recent study conducted by the Rousselot Expertise Center in Ghent in collaboration with UMC Utrecht, in the Netherlands, investigated the role of endotoxins in gelatin and their influence on cellular activity. This is relevant to laboratory scientists performing cell culture in pharmaceutical and biotech companies, hospitals and surgical centers, academic research institutes, Contract Research Organizations (CROs), and cell / tissue banks.

During the study, the effects of endotoxins in gelatin hydrogels on mesenchymal stem cells (MSC) and peripheral blood mononuclear cells (PBMC) cultures were separately examined. It was reported that the production of glycosaminoglycans (GAGs) was higher with X-Pure purified gelatin (<10 EU/g) compared to non-purified gelatin, therefore suggesting better stem cell differentiation in a chondrogenesis assay after 28 days in culture. In PBMC cultures, production of the inflammatory marker TNF-α was significantly higher with non-purified gelatin hydrogels as compared with purified gelatin.

Conference by Jos Olijve
Jos Olijve, Principal scientist and R&D project manager at Rousselot Biomedical will detail the results of the different studies carried out including the one mentioned above in a presentation on the “Influence of Endotoxin on Cellular Activity”. The conference will take place on Wednesday, 6 November 2019 from 15:20 to 15:50 in the Portalhaus, Transparenz 1 Room.

Mentioned Companies
Rousselot Netherlands
View company profile